Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
64.94 USD | +0.19% | +0.53% | +240.71% |
May. 10 | Alpine Immune Sciences, Vertex Pharmaceuticals Deal Crosses Another Milestone | MT |
May. 09 | Alpine Immune Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | 16.15M | Sales 2025 * | 18.79M | Capitalization | 4.26B |
---|---|---|---|---|---|
Net income 2024 * | -101M | Net income 2025 * | -113M | EV / Sales 2024 * | 245 x |
Net cash position 2024 * | 304M | Net cash position 2025 * | 208M | EV / Sales 2025 * | 216 x |
P/E ratio 2024 * |
-39.4
x | P/E ratio 2025 * |
-35.4
x | Employees | 142 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.36% |
Latest transcript on Alpine Immune Sciences, Inc.
1 day | +0.19% | ||
1 week | +0.53% | ||
Current month | +0.54% | ||
1 month | +38.05% | ||
3 months | +123.62% | ||
6 months | +431.42% | ||
Current year | +240.71% |
Managers | Title | Age | Since |
---|---|---|---|
Mitchell Gold
CEO | Chief Executive Officer | 57 | 17-07-23 |
Director of Finance/CFO | - | 17-05-31 | |
Stanford Peng
PSD | President | 53 | 17-07-23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Conway
BRD | Director/Board Member | 70 | 17-06-30 |
Mitchell Gold
CEO | Chief Executive Officer | 57 | 17-07-23 |
James Topper
BRD | Director/Board Member | 62 | 16-05-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.64% | 4 M€ | -5.15% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.01% | 0 M€ | 0.00% | - | |
0.00% | 0 M€ | +9.18% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 64.94 | +0.19% | 3,047,933 |
24-05-09 | 64.82 | +0.19% | 1,141,451 |
24-05-08 | 64.7 | +0.09% | 748,953 |
24-05-07 | 64.64 | +0.06% | 1,332,282 |
24-05-06 | 64.6 | 0.00% | 1,373,829 |
Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+240.71% | 4.26B | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- ALPN Stock